CAR T cell therapies have made great strides in the clinic; however, multiple hurdles limit the efficacy of this approach for solid tumors. A new study has developed an optimized, dual-targeting CAR T cell that overcomes several of these challenges by enhancing T cell persistence and reducing therapy escape due to antigen loss.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy
Cellular & Molecular Immunology Open Access 11 April 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Carpenito, C. et al. Proc. Natl Acad. Sci. USA 106, 3360–3365 (2009).
Milone, M. C. et al. Mol. Ther. 17, 1453–1464 (2009).
MacIver, N. J., Michalek, R. D. & Rathmell, J. C. Annu. Rev. Immunol. 31, 259–283 (2013).
O’Sullivan, D. et al. Immunity 41, 75–88 (2014).
Kawalekar, O. U. et al. Immunity 44, 380–390 (2016).
Hirabayashi, K. et al. Nat. Cancer https://doi.org/10.1038//s43018-021-00244-2 (2021).
Kloss, C. C., Condomines, M., Cartellieri, M., Bachmann, M. & Sadelain, M. Nat. Biotechnol. 31, 71–75 (2013).
Shah, N. N. et al. Nat. Med. 26, 1569–1575 (2020).
Zah, E., Lin, M. Y., Silva-Benedict, A., Jensen, M. C. & Chen, Y. Y. Cancer Immunol. Res. 4, 498–508 (2016).
Heczey, A. et al. Mol. Ther. 25, 2214–2224 (2017).
Feucht, J. et al. Nat. Med. 25, 82–88 (2019).
Wherry, E. J. & Kurachi, M. Nat. Rev. Immunol. 15, 486–499 (2015).
Guedan, S. et al. J. Clin. Invest. 130, 3087–3097 (2020).
Boucher, J. C. et al. Cancer Immunol. Res. 9, 62–74 (2021).
Kofler, D. M. et al. Mol. Ther. 19, 760–767 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
King-Peoples, T.R., Posey, A.D. Splitting signals drives CARs further. Nat Cancer 2, 873–875 (2021). https://doi.org/10.1038/s43018-021-00257-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-021-00257-x
This article is cited by
-
Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy
Cellular & Molecular Immunology (2024)